Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice

Journal of Experimental Medicine

Volumn 208, Issue 1, 2011, Pages 53-66

  Nigro, Patrizia ^a   Satoh, Kimio ^a,b   O'Dell, Michael R ^a   Soe, Nwe Nwe ^a   Cui, Zhaoqiang ^a   Mohan, Amy ^a   Abe, Jun Ichi ^a   Alexis, Jeffrey D ^a   Sparks, Janet D ^a   Berk, Bradford C ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CYCLOPHILIN A; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LOW DENSITY LIPOPROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BONE MARROW CELL; CELL TRANSPLANTATION; CHOLESTEROL DIET; CONTROLLED STUDY; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL MOVEMENT; CYCLOPHILIN A; MACROPHAGES; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING;

EID: 78651502102     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20101174     Document Type: Article

References (57)

1. Allain, F., C. Vanpouille, M. Carpentier, M.C. Slomianny, S. Durieux, and G. Spik. 2002. Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix. Proc. Natl. Acad. Sci. USA. 99:2714-2719. doi:10.1073/pnas.052284899
2. Arora, K., W.M. Gwinn, M.A. Bower, A. Watson, I. Okwumabua, H.R. MacDonald, M.I. Bukrinsky, and S.L. Constant. 2005. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J. Immunol. 175:517-522.
3. Atkins, G.B., and M.K. Jain. 2007. Role of Krüppel-like transcription factors in endothelial biology. Circ. Res. 100:1686-1695. doi:10.1161/01.RES.0000267856.00713.0a
4. Atkins, G.B., Y. Wang, G.H. Mahabeleshwar, H. Shi, H. Gao, D. Kawanami, V. Natesan, Z. Lin, D.I. Simon, and M.K. Jain. 2008. Hemizygous deficiency of Krüppel-like factor 2 augments experimental atherosclerosis. Circ. Res. 103:690-693. doi:10.1161/CIRCRESAHA.108.184663
5. Berk, B.C. 2008. Atheroprotective signaling mechanisms activated by steady laminar flow in endothelial cells. Circulation. 117:1082-1089. doi:10.1161/CIRCULATIONAHA.107.720730
6. Bram, R.J., D.T. Hung, P.K. Martin, S.L. Schreiber, and G.R. Crabtree. 1993. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol. Cell. Biol. 13:4760-4769.
7. Chen, J., P.J. Kuhlencordt, J. Astern, R. Gyurko, and P.L. Huang. 2001. Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice. Circulation. 104:2391-2394. doi:10.1161/hc4501. 099729
8. Chirieac, D.V., L.R. Chirieac, J.P. Corsetti, J. Cianci, C.E. Sparks, and J.D. Sparks. 2000. Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production. Am. J. Physiol. Endocrinol. Metab. 279:E1003-E1011.
9. Colgan, J., M. Asmal, M. Neagu, B. Yu, J. Schneidkraut, Y. Lee, E. Sokolskaja, A. Andreotti, and J. Luban. 2004. Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk. Immunity. 21:189-201. doi:10.1016/j.immuni.2004.07.005
10. Cybulsky, M.I., and M.A. Gimbrone Jr. 1991. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 251:788-791. doi:10.1126/science.1990440
11. Cybulsky, M.I., K. Iiyama, H. Li, S. Zhu, M. Chen, M. Iiyama, V. Davis, J.C. Gutierrez-Ramos, P.W. Connelly, and D.S. Milstone. 2001. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 107:1255-1262. doi:10.1172/JCI11871
12. Damsker, J.M., M.I. Bukrinsky, and S.L. Constant. 2007. Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A. J. Leukoc. Biol. 82:613-618. doi:10.1189/jlb.0506317
13. Everson, W.V., and E.J. Smart. 2001. Influence of caveolin, cholesterol, and lipoproteins on nitric oxide synthase: implications for vascular disease. Trends Cardiovasc. Med. 11:246-250. doi:10.1016/S1050-1738(01)00119-0
14. Fernández-Miranda, C., C. Guijarro, A. de la Calle, C. Loinaz, I. Gonzalez-Pinto, T. Gómez-Izquierdo, S. Larumbe, E. Moreno, and A. del Palacio. 1998. Lipid abnormalities in stable liver transplant recipients - effects of cyclosporin, tacrolimus, and steroids. Transpl. Int. 11:137-142. doi:10.1111/j.1432-2277.1998.tb00789.x
15. Galkina, E., and K. Ley. 2009. Immune and inflammatory mechanisms of atherosclerosis (*). Annu. Rev. Immunol. 27:165-197. doi:10.1146/annurev. immunol.021908.132620
16. Glass, C.K., and J.L. Witztum. 2001. Atherosclerosis. The road ahead. Cell. 104:503-516. doi:10.1016/S0092-8674(01)00238-0
17. Griendling, K.K., and G.A. FitzGerald. 2003. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation. 108:1912-1916. doi:10.1161/01.CIR.0000093660.86242.BB
18. Handa, S., A.M. Sadi, M.I. Cybulsky, D.J. Stewart, and M. Husain. 2008. Region-specific patterns of vascular remodelling occur early in atherosclerosis and without loss of smooth muscle cell markers. Atherosclerosis. 196:617-623. doi:10.1016/j.atherosclerosis.2007.06.032
19. Handschumacher, R.E., M.W. Harding, J. Rice, R.J. Drugge, and D.W. Speicher. 1984. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science. 226:544-547. doi:10.1126/science.6238408
20. Hansson, G.K. 2005. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352:1685-1695. doi:10.1056/NEJMra043430
21. Hansson, G.K., and P. Libby. 2006. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 6:508-519. doi:10.1038/nri1882
22. Jin, Z.G., M.G. Melaragno, D.F. Liao, C. Yan, J. Haendeler, Y.A. Suh, J.D. Lambeth, and B.C. Berk. 2000. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ. Res. 87:789-796.
23. Jin, Z.G., A.O. Lungu, L. Xie, M. Wang, C. Wong, and B.C. Berk. 2004. Cyclophilin A is a proinflammatory cytokine that activates endothelial cells. Arterioscler. Thromb. Vasc. Biol. 24:1186-1191. doi:10.1161/01.ATV.0000130664. 51010.28
24. Kawashima, S., and M. Yokoyama. 2004. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24:998-1005. doi:10.1161/01.ATV.0000125114.88079.96
25. Kawashima, S., T. Yamashita, M. Ozaki, Y. Ohashi, H. Azumi, N. Inoue, K. Hirata, Y. Hayashi, H. Itoh, and M. Yokoyama. 2001. Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling. Arterioscler. Thromb. Vasc. Biol. 21:201-207.
26. Khromykh, L.M., N.L. Kulikova, T.V. Anfalova, T.A. Muranova, V.M. Abramov, A.M. Vasiliev, V.S. Khlebnikov, and D.B. Kazansky. 2007. Cyclophilin A produced by thymocytes regulates the migration of murine bone marrow cells. Cell. Immunol. 249:46-53. doi:10.1016/j.cellimm.2007.11.002
27. Kim, H., W.J. Kim, S.T. Jeon, E.M. Koh, H.S. Cha, K.S. Ahn, and W.H. Lee. 2005. Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages. Clin. Immunol. 116:217-224. doi:10.1016/j.clim.2005. 05.004
28. Knowles, J.W., R.L. Reddick, J.C. Jennette, E.G. Shesely, O. Smithies, and N. Maeda. 2000. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. J. Clin. Invest. 105:451-458. doi:10.1172/JCI8376
29. Kockx, M., W. Jessup, and L. Kritharides. 2010. Cyclosporin A and atherosclerosis - cellular pathways in atherogenesis. Pharmacol. Ther. 128:106-118. doi:10.1016/j.pharmthera.2010.06.001
30. Kuhlencordt, P.J., R. Gyurko, F. Han, M. Scherrer-Crosbie, T.H. Aretz, R. Hajjar, M.H. Picard, and P.L. Huang. 2001. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation. 104:448-454. doi:10.1161/hc2901.091399
31. Li, H., and U. Förstermann. 2009. Prevention of atherosclerosis by interference with the vascular nitric oxide system. Curr. Pharm. Des. 15:3133-3145. doi:10.2174/138161209789058002
32. Liao, D.F., Z.G. Jin, A.S. Baas, G. Daum, S.P. Gygi, R. Aebersold, and B.C. Berk. 2000. Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J. Biol. Chem. 275:189-196. doi:10.1074/jbc.275.1.189
33. López-Miranda, J., E. Vilella, F. Pérez-Jiménez, A. Espino, J.A. Jiménez-Perepérez, L. Masana, and P.R. Turner. 1993. Low-density lipoprotein metabolism in rats treated with cyclosporine. Metabolism. 42:678-683. doi:10.1016/0026-0495(93)90232-D
34. Lungu, A.O., Z.G. Jin, H. Yamawaki, T. Tanimoto, C. Wong, and B.C. Berk. 2004. Cyclosporin A inhibits flow-mediated activation of endothelial nitric-oxide synthase by altering cholesterol content in caveolae. J. Biol. Chem. 279:48794-48800. doi:10.1074/jbc.M313897200
35. Nakashima, Y., A.S. Plump, E.W. Raines, J.L. Breslow, and R. Ross. 1994. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14:133-140.
36. Nakashima, Y., E.W. Raines, A.S. Plump, J.L. Breslow, and R. Ross. 1998. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18:842-851.
37. Oemar, B.S., M.R. Tschudi, N. Godoy, V. Brovkovich, T. Malinski, and T.F. Lüscher. 1998. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation. 97:2494-2498.
38. Ojo, A.O. 2006. Cardiovascular complications after renal transplantation and their prevention. Transplantation. 82:603-611. doi:10.1097/01.tp.0000235527. 81917.fe
39. Pan, H., C. Luo, R. Li, A. Qiao, L. Zhang, M. Mines, A.M. Nyanda, J. Zhang, and G.H. Fan. 2008. Cyclophilin A is required for CXCR4-mediated nuclear export of heterogeneous nuclear ribonucleoprotein A2, activation and nuclear translocation of ERK1/2, and chemotactic cell migration. J. Biol. Chem. 283:623-637. doi:10.1074/jbc.M704934200
40. Parmar, K.M., H.B. Larman, G. Dai, Y. Zhang, E.T. Wang, S.N. Moorthy, J.R. Kratz, Z. Lin, M.K. Jain, M.A. Gimbrone Jr., and G. García- Cardeña. 2006. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J. Clin. Invest. 116:49-58. doi:10.1172/JCI24787
41. Podrez, E.A., D. Schmitt, H.F. Hoff, and S.L. Hazen. 1999. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J. Clin. Invest. 103:1547-1560. doi:10.1172/JCI5549
42. Satoh, K., Y. Kagaya, M. Nakano, Y. Ito, J. Ohta, H. Tada, A. Karibe, N. Minegishi, N. Suzuki, M. Yamamoto, et al. 2006. Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice. Circulation. 113:1442-1450. doi:10.1161/CIRCULATIONAHA.105.583732
43. Satoh, K., T. Matoba, J. Suzuki, M.R. O'Dell, P. Nigro, Z. Cui, A. Mohan, S. Pan, L. Li, Z.G. Jin, et al. 2008. Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation. Circulation. 117:3088-3098. doi:10.1161/CIRCULATIONAHA.107.756106
44. Satoh, K., P. Nigro, T. Matoba, M.R. O'Dell, Z. Cui, X. Shi, A. Mohan, C. Yan, J. Abe, K.A. Illig, and B.C. Berk. 2009. Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat. Med. 15:649-656. doi:10.1038/nm.1958
45. Seizer, P., T. Schönberger, M. Schött, M.R. Lang, H.F. Langer, B. Bigalke, B.F. Krämer, O. Borst, K. Daub, O. Heidenreich, et al. 2010. EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation. Atherosclerosis. 209:51-57. doi:10.1016/j.atherosclerosis. 2009.08.029
46. Sherry, B., N. Yarlett, A. Strupp, and A. Cerami. 1992. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide- activated macrophages. Proc. Natl. Acad. Sci. USA. 89:3511-3515. doi:10.1073/pnas.89.8.3511
47. Suzuki, J., Z.G. Jin, D.F. Meoli, T. Matoba, and B.C. Berk. 2006. Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells. Circ. Res. 98:811-817. doi:10.1161/01.RES.0000216405.85080.a6
48. Tangirala, R.K., E.M. Rubin, and W. Palinski. 1995. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36:2320-2328.
49. Tegeder, I., A. Schumacher, S. John, H. Geiger, G. Geisslinger, H. Bang, and K. Brune. 1997. Elevated serum cyclophilin levels in patients with severe sepsis. J. Clin. Immunol. 17:380-386. doi:10.1023/A:1027364207544
50. Uittenbogaard, A., Y. Ying, and E.J. Smart. 1998. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking. J. Biol. Chem. 273:6525-6532. doi:10.1074/jbc.273.11. 6525
51. Vaziri, N.D., K. Liang, and H. Azad. 2000. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions. J. Pharmacol. Exp. Ther. 294:778-783.
52. Weber, C., A. Zernecke, and P. Libby. 2008. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol. 8:802-815. doi:10.1038/nri2415
53. Weintraub, N.L. 2009. Understanding abdominal aortic aneurysm. N. Engl. J. Med. 361:1114-1116. doi:10.1056/NEJMcibr0905244
54. Won, D., S.N. Zhu, M. Chen, A.M. Teichert, J.E. Fish, C.C. Matouk, M. Bonert, M. Ojha, P.A. Marsden, and M.I. Cybulsky. 2007. Relative reduction of endothelial nitric-oxide synthase expression and transcription in atherosclerosis-prone regions of the mouse aorta and in an in vitro model of disturbed flow. Am. J. Pathol. 171:1691-1704. doi:10.2353/ajpath.2007.060860
55. Xu, Q., M.C. Leiva, S.A. Fischkoff, R.E. Handschumacher, and C.R. Lyttle. 1992. Leukocyte chemotactic activity of cyclophilin. J. Biol. Chem. 267:11968-11971.
56. Yurchenko, V., G. Zybarth, M. O'Connor, W.W. Dai, G. Franchin, T. Hao, H. Guo, H.C. Hung, B. Toole, P. Gallay, et al. 2002. Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J. Biol. Chem. 277:22959-22965. doi:10.1074/jbc.M201593200
57. Zhu, C., X. Wang, J. Deinum, Z. Huang, J. Gao, N. Modjtahedi, M.R. Neagu, M. Nilsson, P.S. Eriksson, H. Hagberg, et al. 2007. Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. J. Exp. Med. 204:1741-1748. doi:10.1084/jem.20070193